FDA (Food and Drug Administration) is a federal agency in the US that protects the public health by supervising dietary supplements, food safety, tobacco products, and pharmaceutical drugs. After the cannabis compound was legalized in 2018 as per the US Farm Bill, the whole CBD industry was looking forward to the stand that FDA will take on the production and sale of CBD therapeutics, food supplements, and personal care products.
US Farm Bill
The Agriculture Improvement Act commonly termed the US Farm Bill came into effect in December 2018. Before the Bill came into effect, CBD products were treated no different from marijuana. Cannabidiol derived from all cannabis sources including hemp and marijuana were enlisted as Federally Controlled Drug Substances. However, the enactment of Farm Bill changed the legal status of CBD hemp and its derivatives.
The Bill defines hemp as the plant Cannabis sativa L. and has made legal any part of that plant including its cannabinoids, seeds, acids, isomers, and salts that has a THC concentration not more than 0.3%. With the new definition, hemp and hemp-derived CBD is no longer a controlled substance in the US.
The Farm bill has granted FDA the exclusive authority to regulate cannabis and cannabis-derived products according to the FD&C Act and Public Health Service Act. Cannabis and cannabis derived products including hemp CBD are treated like every other FDA-regulated product. You can visit https://www.greeny.com for high quality CBD products.
Medical CBD Products Approved By FDA
FDA does not approve the marketing of cannabis as the treatment for any medical condition. However, it has approved a CBD therapeutic and three cannabis-related drugs. To buy them, you should get a prescription from a licensed healthcare provider.
The CBD drug approved by FDA is Epidolex that is used to treat Lennox-Gastaut syndrome and Dravet syndrome, two severe forms of epilepsy that affect people over the age of two. The approval indicates that the FDA regards the drug safe and effective for use.
Marinol and Syndros used in the treatment of anorexia related to weight loss in AIDS patients are approved by the FDA. The drugs have dronabinol, a synthetic THC as its active ingredient. Cesamet is another FDA approved drug that has nabilone, a synthetic compound with a chemical structure resembling THC.
The FDA evaluates the results of research that analyzes the therapeutic effects of CBD and their possible side effects before proceeding with the approval of a CBD drug.